Pyridostigmine Bromide interactions
Checked as Pyridostigmine in this data source.
Full monograph for Pyridostigmine BromideCheck it against another medicine
Medicines
232 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Acyclovir + Hydrocortisone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Alectinib | Moderate | Synergy | Coadministration of alectinib with other agents that can slow the heart rate may increase the risk of bradycardia. | 4 sources — open the full entry |
| Amikacin | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
| Atropine Sulfate (Injection) | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Beclometasone + Formoterol + Glycopyrronium | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Betamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone + Calcipotriol | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone + Clotrimazole | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone + Clotrimazole + Gentamicin | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Betamethasone + Neomycin Sulphate (Ophthalmic) | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Betamethasone + Phenylephrine + Lignocaine | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone Dipropionate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone Dipropionate + Salicylic Acid | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone Sodium Phosphate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Betamethasone Valerate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Bethanechol Chloride | Moderate | Synergy | A synergistic effect may be expected when acetylcholinesterase inhibitors are administered concurrently with other cholinesterase inhibitors or cholinergic… | 3 sources — open the full entry |
| Brigatinib | Moderate | Synergy | Coadministration of brigatinib with other agents that can also slow the heart rate may potentiate the risk of severe bradycardia. | 2 sources — open the full entry |
| BudesonideInhalerNebuliser SuspensionTablet | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Budesonide + Formoterol Fumarate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Budesonide + Glycopyrronium Bromide + Formoterol Fumarate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 6 sources — open the full entry |
| Calcium Dobesilate + Lidocaine + Dexamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Framycetin + Esculin | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Neomycin + Esculin | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Ciprofloxacin + Dexamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Clobetasol Propionate + Neomycin Sulphate + Nystatin | Moderate | Antagonism · Unknown | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between…2 documented mechanisms | 19 sources — open the full entry |
| Clotrimazole + Hydrocortisone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Clozapine | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Crizotinib | Moderate | Synergy | Crizotinib can cause bradycardia and may have additive effects with other drugs that also slow the heart rate. | 4 sources — open the full entry |
| Darifenacin | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Deflazacort | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Dexamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Dexamethasone + Chloramphenicol | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Dexamethasone + Levofloxacin | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Dexamethasone + Neomycin + Glacial Acetic Acid | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Dexamethasone + Neomycin Sulphate + Polymyxin B Sulphate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Dexamethasone + Tobramycin | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 24 sources — open the full entry |
| Dicycloverine Hydrochloride | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Donepezil Hydrochloride | Moderate | Synergy | A synergistic effect may be expected when acetylcholinesterase inhibitors are administered concurrently with other cholinesterase inhibitors or cholinergic… | 3 sources — open the full entry |
| Econazole Nitrate + Triamcinolone Acetonide | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Flavoxate Hydrochloride | Moderate | Antagonism | Anticholinergic agents and other agents with significant anticholinergic activity (e.g., clozapine, class IA antiarrhythmics especially disopyramide) may… | 1 sources — open the full entry |
| Fludrocortisone Acetate | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Fluocinolone Acetonide + Neomycin Sulfate | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
| Fluormetholone + Neomycin Sulphate | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
| Fluorometholone + Gentamicin | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
| Formoterol Fumarate + Glycopyrrolate + Budesonide | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of…2 documented mechanisms | 6 sources — open the full entry |
| Fusidic acid + Betamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Fusidic acid + Hydrocortisone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Gatifloxacin + Dexamethasone | Moderate | Antagonism | Corticosteroids and adrenocorticotropic agents may diminish the therapeutic effects of acetylcholinesterase inhibitors in myasthenia gravis. The mechanism of… | 5 sources — open the full entry |
| Gentamicin + Hydrocortisone Acetate | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
| Gentamicin SulfateInjectionOphthalmic | Moderate | Antagonism | Aminoglycosides may antagonize the effects of anticholinesterase agents such as neostigmine and pyridostigmine. The interaction has been established between… | 19 sources — open the full entry |
Therapeutic duplication
Drug classes that overlap with Pyridostigmine Bromide, so taking both doubles up the same effect. This source publishes no per-row citations for duplication.
cholinergics
The recommended maximum number of medicines in the 'cholinergics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'cholinergics' category.
Example product in the source data (US market): Donepezil/memantine
cholinergics
The recommended maximum number of medicines in the 'cholinergics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'cholinergics' category.
Example product in the source data (US market): Glycopyrrolate/neostigmine